Galapagos NV

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 13 jan 2014 - 07:40

Statutaire naam Galapagos NV

Titel Galapagos receives €2.9 million IWT grant for cystic fibrosis research

Bericht Mechelen, Belgium; 13 January 2014 - Galapagos NV (Euronext: GLPG) announced today that it has been awarded a €2.9 million grant from the Flemish agency for Innovation by Science and Technology (IWT) for cystic fibrosis (CF) research. The goal of this 3-year project is to identify and progress multiple promising CF therapies towards pre-clinical candidates.

Vorige register resultaat

Volgende register resultaat

Gerelateerde downloads

201401130000000003_Galapagos ontvangt €2,9 miljoen subsidie voor onderzoek naar taaislijmziekte.pdf (opens in a new window)

201401130000000003_Galapagos receives €2.9 million IWT grant for cystic fibrosis research.pdf (opens in a new window)

Datum laatste update: 01 september 2024